Trial Profile
Efficacy of a Lenalidomide-Rituximab Regimen prior to Stem Cell Transplantation In Relapsed and/Or Refractory Aggressive B-Cell Non-Hodgkin's Lymphomas: A Single Center Experience
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Aug 2014
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Rituximab
- Indications Diffuse large B cell lymphoma; Follicular lymphoma; Mantle-cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 12 Aug 2014 New trial record